Adaptimmune Therapeutics plc
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2015 | $41.7M | $300.7M | $229.0M |
| FY2016 | $68.4M | $234.5M | $158.8M |
| FY2017 | $78.2M | $281.1M | $84.0M |
| FY2018 | $29.9M | $276.7M | $68.4M |
| FY2019 | $57.9M | $181.5M | $50.4M |
| FY2020 | $109.9M | $451.1M | $56.9M |
| FY2021 | $263.6M | $469.5M | $149.9M |
| FY2022 | $247.0M | $328.9M | $108.0M |
| FY2023 | $243.1M | $282.6M | $144.0M |
| FY2024 | $234.1M | $246.0M | $91.1M |